Provided by Tiger Trade Technology Pte. Ltd.

Syndax Pharmaceuticals

17.60
-0.6200-3.40%
Post-market: 17.770.1700+0.97%19:30 EDT
Volume:2.56M
Turnover:45.28M
Market Cap:1.57B
PE:-7.01
High:18.46
Open:18.46
Low:17.52
Close:18.22
52wk High:25.59
52wk Low:12.99
Shares:89.30M
Float Shares:80.30M
Volume Ratio:1.69
T/O Rate:3.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5100
EPS(LYR):-3.2949
ROE:-255.93%
ROA:-18.67%
PB:104.09
PE(LYR):-5.34

Loading ...

AI Stocks May Have Bottomed Out. What Investors Should Watch for Next.

Dow Jones
·
Aug 01

Earning Preview: Syndax Pharmaceuticals Q2 revenue is expected to increase by 195.71%, and institutional views are bullish

Earnings Agent
·
Jul 29

Apple market value reaches $5 trillion for the first time, Micron plunges on Tuesday trading

Deep News
·
Jul 29

Semiconductor Stocks Plunge as AMD, Micron, and NVIDIA Continue Their Decline

Deep News
·
Jul 28

Syndax to Report Q2 2026 Results, Host Conference Call and Webcast

Reuters
·
Jul 28

Top 20 US Stocks by Trading Volume: AMD Announces Strategic Partnership with Anthropic

Deep News
·
Jul 23

Top 20 US Stocks by Trading Volume on July 22: Micron's Market Cap Reclaims $1 Trillion

Deep News
·
Jul 22

Syndax Pharmaceuticals (SNDX) Receives a New Rating from a Top Analyst

TIPRANKS
·
Jul 20

TradingKey Daily Market Briefing: Oil Prices Rise Above $90, AI Semiconductors Continue to Face Pressure, Nvidia, TSMC, AMD Fall Collectively

TradingKey
·
Jul 20

AI Chip Sell-Off Enters Third Straight Session: Why Are NVDA, AMD, Intel, Micron, and SNDK Falling Today, 7/17/26?

TIPRANKS
·
Jul 17

Tech and Chip Stocks Plunge as Wall Street Volatility Resurfaces

Deep News
·
Jul 17

Top 20 US Stocks by Trading Volume on July 17: Google Delays Launch of Gemini Flagship Model

Deep News
·
Jul 17

Syndax Pharmaceuticals (SNDX) Could Be 40% Undervalued As Pipeline Updates Sharpen Growth Story

Simply Wall St.
·
Jul 16

Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX) and Rhythm Pharmaceuticals (RYTM)

TIPRANKS
·
Jul 15

Syndax Pharmaceuticals Price Target Maintained with a $40.00/share by HC Wainwright & Co.

Dow Jones
·
Jul 15

Analysts Have Conflicting Sentiments on These Healthcare Companies: HCA Healthcare (HCA) and Syndax Pharmaceuticals (SNDX)

TIPRANKS
·
Jul 15

Syndax Posts R&D Day Presentation on Revumenib and Axatilimab Pipeline Expansion

Reuters
·
Jul 14

Syndax Unveils Mutant-selective EGFR Inhibitor Sndx-4321, Targets IND Filing by End-2026

Reuters
·
Jul 14

Semiconductor Stocks Drag Down US Index Futures; SK hynix Slides 10% in Premarket

Deep News
·
Jul 13

Micron, Delta, Strategy, Circle Internet, and More Stocks That Explain Today's Market

Dow Jones
·
Jul 10